PharmaBoardroom

Interview with Francesco De Santis, President, Italfarmaco

Italfarmaco counts amongst the few players who really sustained the growth of the Italian pharmaceutical industry in the past 10 years. Which…

Interview with Woo-Taik Chung, Chungcheongbuk-do Governor,…

Although Chungcheongbuk-do is a small province in terms of territory and population, it has gained increasing importance in Korea’s economy.…

Interview with Massimo Di Martino, President & Managing…

You created Abiogen in 1997, following the acquisition of Istituto Gentili by MSD, in order to maintain your family’s entrepreneurial tradition,…

Interview with Rafael Gual, Director General, CANIFARMA

This is your third interview with Focus Reports. In 2004 and 2008 you were Director of AMIIF, before that you were Director of ANAFAM, and now we’re…

Interview with Rogelio Ambrosi, President, CANIFARMA

There have been quite a few regulatory changes in the last few years such as the new drug registration process and the suppression of the local plant…

Interview with Alberto Aleotti, Chairman & CEO, Menarini

After 67 years in the pharmaceutical industry, of which 45 at the head of Menarini, what would you say have been your personal keys to success? Most…

Interview with Jeung-Soo Kim, President, Korea Pharmaceutical…

Could you please introduce KPMA and explain the role it plays within the South Korean pharmaceutical industry? KPMA is the only association in South…

Interview with Seokmin Yoon, President, ADM Korea

How did you first get involved in clinical trials and what inspired you to create your own CRO, ADM Korea? When I was working at CJ, the company was…

Interview with In-Chull Kim, CEO, LG Life Sciences

LG Life Sciences seems quite unique among the rest of pharmaceutical companies in Korea which tend to be family owned. How has this set LGLS apart in…